Patrizia Burra

Q: What Schools Are Affiliated With Patrizia Burra

Patrizia Burra is affiliated with the following schools: University of Milan, University of Padua

Patrizia Burra's AcademicInfluence.com Rankings

Patrizia Burra

Computer Science

#6754

World Rank

#7118

Historical Rank

Machine Learning

#2296

World Rank

#2324

Historical Rank

Artificial Intelligence

#2569

World Rank

#2610

Historical Rank

Database

#3839

World Rank

#3995

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Patrizia Burra's Degrees

PhD Computer Science University of Milan
Masters Computer Science University of Milan
Bachelors Computer Science University of Milan

Similar Degrees You Can Earn

Why Is Patrizia Burra Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Patrizia Burra's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EASL Clinical Practice Guidelines: Liver transplantation. (2016) (502)
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. (2004) (460)
Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness (2008) (422)
Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. (1995) (390)
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. (1999) (349)
Liver Transplantation for the Treatment of Moderately or Well-Differentiated Hepatocellular Carcinoma (2004) (305)
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial (2015) (301)
Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis (2012) (299)
Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry) (2010) (289)
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation (2008) (274)
Prophylaxis and treatment of hepatitis B in immunocompromised patients. (2007) (225)
β‐Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta‐analysis (2009) (215)
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. (2012) (210)
CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. (2006) (203)
Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group (2017) (191)
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)1 (2002) (187)
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? (2004) (183)
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial (2016) (182)
Management of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Transplantation: A Systematic Review (2012) (182)
New insights into the coagulopathy of liver disease and liver transplantation. (2006) (168)
Advancing the global public health agenda for NAFLD: a consensus statement (2021) (167)
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. (2015) (166)
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. (2001) (151)
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. (2017) (150)
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma (2010) (148)
A Multistep, Consensus‐Based Approach to Organ Allocation in Liver Transplantation: Toward a “Blended Principle Model” (2015) (147)
The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. (2000) (146)
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. (2011) (145)
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review (2014) (140)
Adherence in liver transplant recipients (2011) (129)
Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study. (2018) (123)
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. (2018) (123)
Quality of life following organ transplantation (2007) (118)
Liver transplantation for HCV cirrhosis: Improved survival in recent years and increased severity of recurrent disease in female recipients: Results of a long term retrospective study (2007) (117)
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality (2021) (114)
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost‐benefit analysis while awaiting data on sorafenib safety (2010) (113)
Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. (2007) (108)
Intention‐to‐Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria (2007) (106)
Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease (1994) (100)
Influence of steroids on HCV recurrence after liver transplantation: A prospective study. (2007) (99)
Detection of circulating intercellular adhesion molecule–1 in chronic liver diseases (1992) (97)
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. (2007) (96)
Double-Blind Comparison of Hepatitis C Histological Recurrence Rate in HCV+ Liver Transplant Recipients Given Basiliximab+Steroids or Basiliximab+Placebo, in addition to Cyclosporine and Azathioprine (2004) (95)
Changing attitude to organ donation and transplantation in university students during the years of medical school in Italy. (2005) (94)
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. (2013) (94)
Balancing Donor and Recipient Risk Factors in Liver Transplantation: The Value of D‐MELD With Particular Reference to HCV Recipients (2011) (90)
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? (2018) (87)
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. (2014) (86)
Histological features after liver transplantation in alcoholic cirrhotics. (2001) (82)
Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. (2009) (82)
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma (2007) (79)
Nonadherent behaviors after solid organ transplantation. (2011) (78)
Liver abnormalities and endocrine diseases. (2013) (77)
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation (2007) (75)
Mortality in liver transplant recipients with portal vein thrombosis – an updated meta‐analysis (2018) (74)
Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry (2010) (73)
Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. (1993) (73)
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching. (2011) (72)
Neuropsychological alterations in hepatitis C infection: the role of inflammation. (2011) (70)
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. (2017) (70)
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. (2010) (70)
Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis (2012) (69)
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates. (2017) (69)
Veno occlusive disease: update on clinical management. (2007) (69)
NAFLD and liver transplantation: Disease burden, current management and future challenges (2020) (69)
Long-Term Follow-Up and Outcome of Liver Transplantation From Anti-Hepatitis C Virus-Positive Donors: A European Multicentric Case-Control Study (2011) (68)
Histology predicts cirrhotic evolution of post transplant hepatitis C (2002) (65)
Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury (2012) (65)
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting (2019) (64)
Response to Therapy as a Criterion for Awarding Priority to Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation (2010) (64)
Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement. (2014) (64)
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. (2010) (63)
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. (2014) (63)
Allocation of Liver Grafts Worldwide Is there a best System? (2019) (62)
Bone Metabolism and Gonad Function in Male Patients Undergoing Liver Transplantation: A Two-Year Longitudinal Study (2001) (61)
Current challenges and future directions for liver transplantation (2017) (60)
Is the intercellular adhesion molecule-1/leukocyte function associated antigen 1 pathway of leukocyte adhesion involved in the tissue damage of alcoholic hepatitis? (1992) (59)
Neoplastic disease after liver transplantation: Focus on de novo neoplasms. (2015) (57)
Influence of Age and Gender Before and After Liver Transplantation (2013) (57)
Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? (2006) (57)
Liver transplantation in alcoholic patients (2005) (57)
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). (2019) (57)
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement (2011) (56)
Bone metabolism in orthotopic liver transplantation: a prospective study. (1998) (54)
Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation. (2019) (53)
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients. (2017) (53)
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma. (2017) (52)
Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure? (2010) (52)
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein‐Barr virus (EBV) infection (2000) (51)
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals (2017) (51)
11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. (1993) (50)
Kaposi’s Sarcoma in Transplant and HIV-infected Patients: An Epidemiologic Study in Italy and France (2005) (50)
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. (2009) (49)
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. (2009) (49)
Markers of acute rejection and graft acceptance in liver transplantation. (2015) (47)
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. (2006) (46)
Torque Teno virus: any pathological role in liver transplanted patients? (2008) (46)
HBV and HCV infections in heart transplant recipients. (2001) (46)
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. (2012) (45)
Management of infections in cirrhotic patients: report of a consensus conference. (2014) (45)
Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006. (2009) (44)
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. (2013) (44)
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis. (2018) (44)
Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered (2009) (44)
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. (2020) (44)
Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. (1998) (43)
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma (2018) (43)
The protective effects of L‐arginine after liver ischaemia/reperfusion injury in a pig model (1997) (43)
A Prospective Policy Development to Increase Split-Liver Transplantation for 2 Adult Recipients: Results of a 12-Year Multicenter Collaborative Study (2014) (43)
Donor livers with steatosis are safe to use in hepatitis C virus–positive recipients (2009) (42)
The survival benefit of liver transplantation in hepatocellular carcinoma patients. (2010) (42)
Biopsy‐proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal (2016) (41)
Long‐term medical and psycho‐social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease (2000) (41)
The concept of quality of life in organ transplantation. (2007) (40)
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant (2020) (39)
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis (2019) (39)
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. (2004) (38)
Risk Factors for Central Pontine and Extrapontine Myelinolysis After Liver Transplantation: A Single-Center Study (2015) (38)
Killer cell immunoglobulin‐like receptor genotype and killer cell immunoglobulin‐like receptor–human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation (2009) (38)
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? (2012) (38)
Managing severe alcoholic hepatitis complicated by renal failure. (1993) (38)
Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice (2015) (38)
Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins (2007) (37)
Reversal of hypercoagulability in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals (2018) (35)
Understanding of and attitudes to organ donation and transplantation: a survey among Italian university students (2006) (35)
Partial hepatectomy as first‐line treatment for patients with hepatocellular carcinoma (2007) (34)
Sexual dysfunction after liver transplantation (2009) (33)
Skin cancer and other cutaneous disorders in liver transplant recipients. (2012) (33)
Liver transplantation for viral hepatitis in 2015. (2016) (32)
The Health Care Transition of Youth With Liver Disease Into the Adult Health System: Position Paper From ESPGHAN and EASL (2018) (32)
Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. (2020) (31)
Including Relative Adrenal Insufficiency in Definition and Classification of Acute on Chronic Liver Failure. (2020) (31)
AISF position paper on liver disease and pregnancy. (2016) (30)
Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe. (2011) (30)
Dynamic tests to study liver function. (2004) (30)
A Global Survey of Physicians Knowledge About Non-alcoholic Fatty Liver Disease. (2021) (30)
Risk factors in liver retransplantation: a single-center experience. (2011) (29)
Understanding of and attitudes to xenotransplantation: a survey among Italian university students (2004) (29)
Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of Cirrhosis (2020) (29)
Age and equity in liver transplantation: An organ allocation model (2015) (29)
Therapeutic approaches for portal biliopathy: A systematic review (2016) (29)
Effect of penicillamine and zinc on iron metabolism in Wilson's disease (2007) (29)
The transjugular route: the key hole to the liver world. (2007) (28)
HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation. (2006) (28)
Acellular liver matrix improves the survival and functions of isolated rat hepatocytes cultured in vitro. (2004) (27)
Quality of life and adherence in liver transplant recipients. (2018) (27)
De novo autoimmune hepatitis after liver transplantation. (2011) (27)
Liver Transplantation for Alcoholic Liver Disease. (2013) (27)
Machine Perfusions in Liver Transplantation: The Evidence‐Based Position Paper of the Italian Society of Organ and Tissue Transplantation (2020) (27)
Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma (2018) (27)
Longitudinal prospective study on quality of life and psychological distress before and one year after liver transplantation. (2005) (27)
Microwave thermal ablation for hepatocarcinoma: six liver transplantation cases. (2011) (27)
Balancing Utility and Need by Means of Donor‐to‐Recipient Matching: A Challenging Problem (2013) (26)
Female gender in the setting of liver transplantation. (2014) (26)
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? (2015) (26)
Hepatitis C virus infection in end‐stage renal disease and kidney transplantation (2014) (26)
Should donors and recipients be matched in liver transplantation? (2006) (26)
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study (2018) (26)
Infections and Organ Transplantation: New Challenges for Prevention and Treatment—A Colloquium (2012) (26)
Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation. (2005) (26)
The adolescent and liver transplantation. (2012) (25)
Physical activity in solid organ transplant recipients: organizational aspects and preliminary results of the Italian project. (2014) (25)
Lack of agreement for defining ‘clinical suspicion of rejection’ in liver transplantation: a model to select candidates for liver biopsy (2015) (25)
The effect of recurrence of HCV infection of life after liver transplantation (1998) (25)
Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) (2021) (25)
Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome (2020) (25)
Severity of alcoholic liver disease and markers of thyroid and steroid status. (1992) (24)
Ethical review of COVID-19 vaccination requirements for transplant center staff and patients (2021) (24)
Growth hormone/insulin‐like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study (2004) (23)
Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience. (2006) (23)
The Impact of Hepatitis C and Biliary Complications on Patient and Graft Survival Following Liver Transplantation (2009) (23)
Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients. (2009) (23)
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study (2018) (23)
Polyclonal and monoclonal B lymphocytes response in HCV‐infected patients treated with direct‐acting antiviral agents (2017) (22)
Macroenzymes: too often overlooked. (2003) (22)
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. (1992) (22)
ABO Blood Group-Related Waiting List Disparities in Liver Transplant Candidates: Effect of the MELD Adoption (2008) (22)
18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation. (1999) (22)
Neurologic complications after solid organ transplantation. (2009) (22)
Management of hepatitis C virus infection recurrence after liver transplantation: an overview. (2011) (21)
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis. (2016) (21)
Strengthening acceptance for xenotransplantation: the case of attraction effect (2008) (21)
Risk of virus and non‐virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 (2018) (21)
Survival after the diagnosis of de novo malignancy in liver transplant recipients (2018) (21)
New Perspectives in Liver Transplantation: From Regeneration to Bioengineering (2019) (20)
Combined liver-kidney transplantation in a 15-year-old boy with alpha1-antitrypsin deficiency. (2002) (20)
Trends in liver transplantation 2011. (2012) (20)
Organ Preservation in Liver Transplantation (2018) (20)
Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis? (2004) (19)
Liver transplantation in Italy: current status (2000) (19)
Long‐term quality of life for transplant recipients (2013) (19)
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study (2013) (19)
Invasive fungal infection before and after liver transplantation (2020) (19)
Common issues in the management of patients in the waiting list and after liver transplantation. (2017) (18)
A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3) (2014) (18)
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? (2009) (18)
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute‐on‐chronic liver failure (2021) (18)
Long-term care of transplant recipients: de novo neoplasms after liver transplantation (2018) (18)
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF). (2016) (18)
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT CANDIDATES. (2017) (18)
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics (2019) (18)
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death. (2022) (18)
Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation. (2021) (18)
Is osteoporosis a peculiar association with primary biliary cirrhosis? (2005) (18)
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. (2010) (17)
Bax Inhibitor-1 down-regulation in the progression of chronic liver diseases (2010) (17)
Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon. (1996) (17)
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing. (2003) (17)
Management of bacterial infection in the liver transplant candidate (2018) (17)
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver’s early regeneration after auxiliary partial orthotopic liver transplantation (2004) (17)
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis (2018) (17)
Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease. (2006) (17)
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18 (2015) (17)
Therapeutic application of stem cells in gastroenterology: an up-date. (2011) (17)
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy (2012) (17)
Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistance (2020) (16)
Primary biliary cirrhosis: Symptomatic treatment (1991) (16)
Sex-dependent differences in inflammatory responses during liver regeneration in a murine model of acute liver injury. (2017) (16)
Specific issues concerning the management of patients on the waiting list and after liver transplantation (2018) (16)
Understanding of and attitude to xenotransplantation among Italian university students: impact of a 3‐yr university course (2006) (16)
Management of Helicobacter pylori infection: Guidelines of the Italian society of gastroenterology (SIGE) and the Italian society of digestive endoscopy (SIED). (2022) (16)
Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis (2021) (16)
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study. (2019) (16)
Machine learning in liver transplantation: a tool for some unsolved questions? (2021) (16)
Development and validation of a questionnaire evaluating the impact of hepatitis B immune globulin prophylaxis on the quality of life of liver transplant recipients (2012) (16)
Italian association for the study of the liver position statement on SARS-CoV2 vaccination (2021) (15)
Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation. (2011) (15)
Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand? (2022) (15)
Hepatitis C virus and liver transplantation: where do we stand? (2016) (15)
Functional and morphological graft monitoring after liver transplantation. (2001) (15)
Influence of donor and recipient gender on liver transplantation outcomes in Europe (2016) (14)
http://www.D‐MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation (2012) (14)
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis (2019) (14)
The Lancet–EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities (2018) (14)
Head and neck and esophageal cancers after liver transplant: results from a multicenter cohort study. Italy, 1997–2010 (2015) (14)
Incidence of Second Primary Cancer in Transplanted Patients (2006) (13)
Micronuclei and broken eggs in human liver carcinogenesis. (2008) (13)
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC (2021) (13)
Sorafenib use in the transplant setting (2014) (13)
Orthotopic liver transplantation in non-alcoholic fatty liver disease patients. (2015) (13)
Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study. (2012) (13)
Alcohol abuse and de novo tumors in liver transplantation. (2009) (13)
Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study. (2021) (13)
People’s attitude toward xenotransplantation: affective reactions and the influence of the evaluation context (2009) (12)
Cardiovascular assessment I (1992) (12)
Physical Condition, Glycemia, Liver Function, and Quality of Life in Liver Transplant Recipients After a 12-Month Supervised Exercise Program. (2019) (12)
Utility‐based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha‐fetoprotein model as a survival predictor (2015) (12)
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times (2018) (12)
Prognostic evaluation of the donor risk index among a prospective cohort of Italian patients undergoing liver transplantation. (2009) (12)
Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors (2017) (11)
Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis (2017) (11)
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection (2020) (11)
Can liver transplantation provide the statistical cure? (2014) (11)
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology (2020) (11)
Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation (2021) (11)
Clinical and Patient Reported Outcomes from Patients with Non-alcoholic Fatty Liver Disease Across the World: Data from the Global NASH/NAFLD Registry. (2021) (11)
Frontal cerebral blood flow is impaired in patients with heart transplantation (2002) (11)
Liver transplantation and pregnancy (1995) (10)
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections (2022) (10)
Outcomes of Liver Transplant for Adults With Wilson’s Disease (2020) (10)
Warm Hepatic Ischemia in Pigs: Effects of L-Arginine and Oligotide Treatment (2001) (10)
Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures (2020) (10)
New Indications for Liver Transplantation (2021) (10)
The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability. (2019) (10)
COVID-19 and liver disease: where are we now? (2022) (10)
Laboratory test scores to aid identification of primary nonfunction of liver transplants. (1995) (10)
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation. (2022) (10)
The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage. (2019) (10)
International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS. (2017) (10)
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study (2021) (10)
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis. (2022) (10)
Hepatitis C Infection in Patients with Chronic Kidney Disease (2008) (10)
Short‐term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service (2018) (10)
MODERATELY OR WELL-DIFFERENTIATED HEPATOCELLULAR-CARCINOMA AND LIVER TRANSPLANTATION (2004) (10)
Vanishing bile duct syndrome (1992) (10)
Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease (2000) (10)
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor (2020) (9)
Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report. (1995) (9)
Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications (2022) (9)
Bile duct stones and casts after liver transplantation: Different entities but similar prevention strategy? (2008) (9)
The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin (2021) (9)
Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft (2004) (9)
Model for end‐stage liver disease‐sodium and survival benefit in liver transplantation (2013) (9)
Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation. (2010) (9)
Comparison of fondaparinux and low molecular weight heparin in the treatment of portal vein thrombosis in cirrhosis. (2021) (9)
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study (2017) (9)
De novo and recurrent malignancy. (2020) (8)
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study (2021) (8)
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients (2022) (8)
Treatment of genotype‐1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers (2013) (8)
Hepatitis C. (2009) (8)
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. (2013) (8)
Zinc, iron, and peroxidation in liver tissue (2007) (8)
Natural α-IFN in HCV recurrence after liver transplantation (2001) (8)
The application of artificial intelligence in hepatology: A systematic review. (2021) (8)
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated cirrhosis: Results of a randomized controlled clinical trial (2015) (8)
Combined liver and kidney transplantation: analysis of Padova experience. (2007) (8)
Experimental hepatology applied to stem cells. (2008) (8)
Cost‐effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation (2015) (8)
Inflammatory bowel disease therapies adversely affect fertility in men- A systematic review and meta-analysis. (2019) (7)
Recent Advances in the Management of Acute Variceal Hemorrhage (2021) (7)
Myocardial perfusion scintigraphy in patients with liver cirrhosis evaluated for orthotopic liver transplantation. (2001) (7)
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals (2020) (7)
A novel approach to severe acute pancreatitis in sequential liver–kidney transplantation: the first report on the application of VAC therapy (2011) (7)
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation. (2021) (7)
Successful pregnancy in Alagille Syndrome. (2015) (7)
Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients (2022) (6)
P915 PREDICTION OF RECURRENCE AFTER LIVER TRANSPLANTATION FOR HCC: VALIDATION OF THE AFP MODEL IN AN ITALIAN COHORT (2014) (6)
New Perspectives on Treatment of Hepatitis B Before and After Liver Transplantation. (2016) (6)
Timing for treatment of HCV recurrence after liver transplantation: the earlier the better (2016) (6)
Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review. (2010) (6)
Sex bias in clinical trials in gastroenterology and hepatology (2022) (6)
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS‐CoV‐2 infection (2021) (6)
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? (2017) (6)
Early predictive markers of irreversible graft dysfunction after liver transplantation. (1994) (6)
[Ulcer and hepatic cirrhosis. Epidemiologic and clinical correlations]. (1991) (6)
Liver transplantation in Italy: current status. Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.). (2000) (6)
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C. (2013) (6)
ALGORITHM FOR THE MANAGEMENT OF PORTAL VEIN THROMBOSIS (PVT) IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE CASE-CONTROL STUDY (2010) (6)
Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial. (2004) (6)
Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients (2021) (5)
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort (2022) (5)
Strategies for liver support: from stem cells to xenotransplantation. (2004) (5)
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation (2019) (5)
Health‐related quality of life in liver transplantation: another step forward (2019) (5)
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites (2018) (5)
O093 : The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis : Results of a randomized controlled clinical trial (2015) (5)
Molecular Refinement of Clinical Staging in Hepatocellular Carcinoma Patients Evaluated for Potentially Curative Therapies (2011) (5)
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation (2021) (5)
Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910–916) (2010) (5)
COVID‐19 and digestive health: Implications for prevention, care and the use of COVID‐19 vaccines in vulnerable patients (2021) (5)
Pancreatic melanoma metastasis diagnosed by endoscopic ultrasound-guided SharkCore biopsy (2016) (5)
The road map toward an hepatitis C virus‐free transplant population (2018) (5)
Physiological and clinical implications of proANP(1-98) circulating levels in the perioperative phase of liver transplantation. (2001) (5)
EFFECTS OF NON-SELECTIVE beta-BLOCKERS ON HEMODYNAMICS AFTER LARGE VOLUME PARACENTESIS IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION: A PRELIMINARY REPORT (2014) (5)
Single-photon emission computed tomography with 99mTC-hexamethylpropyleneamineoxide in cirrhotic patients before and after liver transplantation. (1994) (5)
Metabolic activity of rat hepatocytes cultured on homologous acellular matrix and transplanted into Gunn rats. (2006) (5)
Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF. (2019) (5)
Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection. (2014) (5)
563 ACUTE AND CHRONIC REJECTION DURING INTERFERON THERAPY IN HCV RECURRENT TRANSPLANT PATIENTS: RESULTS FORM THE AISF-RECOLT-C GROUP (2011) (5)
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy (2019) (5)
Drug induced liver injury: from pathogenesis to liver transplantation. (2020) (4)
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma. (2020) (4)
Results of a multicenter, randomized, open-label, controlled clinical trial comparing basiliximab versus steroids in hepatitis C positive liver transplant recipients (2007) (4)
Erratum to “A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list” [J Hepatol 2013;60:290–297] (2014) (4)
OC.19.2 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS (2014) (4)
Health Related Quality of Life in the Major Liver Conditions (2013) (4)
LONG TERM FOLLOW-UP AND OUTCOME OF LIVER TRANSPLANTATION FROM HCV POSITIVE DONORS: A EUROPEAN MULTICENTRIC CASE-CONTROL STUDY: 1110 (2010) (4)
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation – a multicenter cohort study (2021) (4)
Staging the pre-procedural prophylaxis in decompensated cirrhosis. (2022) (4)
HCC recurrence under all-oral DAAs-based antiviral therapy in HCV-infected patients: data from Navigatore web platform (2018) (4)
Algorithm for prioritization of patients on the waiting list for liver transplantation. (2007) (4)
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension. (2016) (4)
Stem cells in hepatology (2008) (4)
The Impact of De novo Tumors after Liver Transplantation on Long Term Survival (2012) (4)
HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage? (2008) (4)
HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis (2020) (4)
Reply to “Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis” (2022) (4)
P930 BLEEDING-UNRELATED MORTALITY IS NOT INCREASED IN PATIENTS WITH CIRRHOSIS AND ASCITES ON TREATMENT WITH β-BLOCKERS: A META-ANALYSIS (2014) (4)
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria (2021) (4)
100 Peginterferon alfa-2A (40KD) with or without ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Preliminary report of a randomized study (2004) (4)
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). (2021) (4)
Sars‐Cov‐2 vaccination in liver transplant recipients: The ‘holy grail’ in a hostile environment (2022) (4)
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria (2021) (4)
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy (2021) (4)
Cyanoacrylate injection to treat recurrent bleeding from Dieulafoy's lesion. (2013) (4)
Diagnostic and prognostic performance of urinary neutrophil gelatinase‐associated lipocalin in patients with cirrhosis and acute kidney injury (2022) (4)
Assessment of Bleeding Risk in Patients with Cirrhosis (2015) (4)
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). (2021) (4)
Digestive cancer screening across Europe (2022) (4)
Liver Transplantation for T2 Hepatocellular Carcinoma during the COVID-19 Pandemic: A Novel Model Balancing Individual Benefit against Healthcare Resources (2021) (4)
Position paper on liver and kidney diseases from the Italian Association for the Study of Liver (AISF), in collaboration with the Italian Society of Nephrology (SIN). (2021) (4)
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life (2013) (3)
Solid Organ Transplantation During COVID-19 Pandemic: An International Web-based Survey on Resources’ Allocation (2021) (3)
85 INTERACTION BETWEEN CYCLOSPORINE AND RECIPIENT IL-28B RS12979860 C>T GENETIC POLYMORPHISMS IN THE ACHIEVEMENT OF SUSTAINED VIRAL RESPONSE FOR RECURRENT HEPATITIS C (2012) (3)
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation (2022) (3)
Generation and Performance of Outcome Indicators in Liver Disease: The Value Based Medicine in Hepatology Study (VBMH) (2013) (3)
Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis (1992) (3)
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation (2022) (3)
Use of HBcAb Positive Liver Grafts. Medium Term Results According to Donor-Recipient Risk Factors (2011) (3)
Human natriuretic factor in cirrhotic patients undergoing orthotopic liver transplantation (1995) (3)
T-44 Impact of antiviral therapy on fibrosis progression due to HCV recurrence after liver transplantation: Results from the AISF RECOLT-C study group (2011) (3)
Transplantation for acute alcoholic hepatitis (2017) (3)
Women Leadership in Liver Transplantation—Results of an International Survey (2022) (3)
Direct-acting antivirals and hepatocellular carcinoma occurrence and recurrence in hepatitis C virus-related liver cirrhosis: fact or finction (2018) (3)
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management (2022) (3)
Geotrichum capitatum Invasive Infection Early After Liver Transplant. (2019) (3)
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. (2014) (3)
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort. (2018) (3)
Drug induced liver injury: from pathogenesis to liver transplantation (2021) (3)
GH/GHBP changes in the perioperative course of liver transplantation: pathophysiologic and clinical implications. (2001) (3)
Gastrectomy, lack of gastric first pass metabolism of ethanol and alcoholic liver disease. Results of a multicentre study. (1997) (3)
846 Is the Primary Immunosuppressive Drug (Cyclosporin a or Tacrolimus) Playing a Role on the Response to Antiviral Treatment for Post-Transplant HCV Recurrence? (2012) (3)
Natural alpha-IFN in HCV recurrence after liver transplantation. (2001) (3)
COMPARISON BETWEEN NIFEDIPINE AND CARVEDILOL IN THE TREATMENT OF “DE NOVO” ARTERIAL HYPERTENSION AFTER LIVER TRANSPLANTATION (LT): PRELIMINARY RESULTS OF A CONTROLLED CLINICAL TRIAL. (2004) (3)
Fondaparinux vs low molecular weight heparin in the treatment of non malignant portal vein thrombosis in patients cirrhosis (2019) (3)
Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation (2020) (3)
The effects of ethanol, 3,5,3'-triiodothyronine (T3) and oestradiol (E2) on thyroid hormone nuclear receptor expression in human hepatocyte primary cultures. (1995) (3)
HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma. (2008) (3)
Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or “Wait and See” Strategy? (2021) (3)
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model (2022) (3)
Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease (2007) (3)
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF). (2013) (2)
Energy expenditure (EE) and substrate utilization (SU) in the perioperative period in orthotopic liver transplantation (OLTX). (1995) (2)
Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis (2022) (2)
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature (2021) (2)
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! (2021) (2)
FACTORS ASSOCIATED WITH RECURRENCE OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION AND EFFECTS ON GRAFT AND PATIENT SURVIVAL (2019) (2)
479 THE RELATIONSHIP BETWEEN SEXUAL DYSFUNCTION, DEPRESSION AND QUALITY OF LIFE AMONG FEMALE BEFORE AND AFTER LIVER TRANSPLANTATION (2009) (2)
Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long? (2011) (2)
Severe acute alcoholic hepatitis: can we offer early liver transplantation? (2020) (2)
Liver transplantation for alcoholic liver disease (2013) (2)
Study of the microcirculation in hDAF transgenic rat livers xenoperfused with human blood (2009) (2)
378 A significant proportion of myofibroblasts in human liver cirrhosis are of bone marrow origin (2003) (2)
The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): a post-hoc between-sex analysis (2019) (2)
Can we match donors and recipients in a cost‐effective way? (2013) (2)
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance. (2000) (2)
Analysis of clinical course of portal vein thrombosis in cirrhosis with hepatocellular carcinoma (2021) (2)
Severe small bowel pneumatosis in adult heart transplant recipient (2015) (2)
Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease. (2021) (2)
Antibiotic therapy for spontaneous bacterial peritonitis in acute-on-chronic liver failure: Handle with care. (2019) (2)
Liver transplantation: indications and outcomes. (2018) (2)
HBV-positive and HIV-positive organs in transplantation: a clinical guide for the hepatologist. (2022) (2)
PREVALENCE AND RISK FACTORS OF METABOLIC SYNDROME AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE (2016) (2)
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients. (2016) (2)
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection (2000) (2)
MALATTIA ULCEROSA E CIRROSI EPATICA : CORRELAZIONI EPIDEMIOLOGICHE E CLINICHE (1991) (2)
235 PREDICTORS OF RESPONSE TO ANTICOAGULANT THERAPY FOR THE TREATMENT OF PORTAL VEIN THROMBOSIS (PVT) IN CIRRHOSIS PATIENTS (2013) (2)
Malnourished cirrhotic patient: what should we do? (2021) (2)
Management of portal hypertension severe complications. (2020) (2)
The role of preoperative optimization of the nutritional status on the improvement of short‐term outcomes after liver transplantation? A review of the literature and expert panel recommendations (2022) (2)
ACUTE ALLOGRAFT REJECTION AFTER LIVER TRANSPLANTATION: INCIDENCE, RISK FACTORS AND IMPACT ON OUTCOME (2010) (2)
Circulating Microparticles and Risk of Portal Vein Thrombosis in Patients with Liver Cirrhosis and Hepatocellular Carcinoma (2016) (2)
Hepatitis C virus infection in end stage renal disease and after kidney transplant. (2014) (2)
Bidimensional shear wave elastography of the rectus femoris muscle in patients with cirrhosis (2020) (1)
36 OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION (2011) (1)
Humoral and cellular immune responses to SARS-CoV-2 vaccination across multiple vaccine platforms and liver disease types: an EASL registry multicentre prospective cohort study (2022) (1)
The role of hepatitis C virus eradication with DAA on insulin resistence regulation (2018) (1)
Organ allocation for liver transplantation: One size does not fill all (2016) (1)
Outcome of Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC) According to Different Transplant Criteria: A Meta-Analysis (2011) (1)
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool (2022) (1)
Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome (2019) (1)
P.1.3: ACUTE AND CHRONIC REJECTION DURING INTERFERON THERAPY IN HCV RECURRENT LIVER TRANSPLANT PATIENTS: RESULTS FROM THE AISF-RECOLT-C GROUP (2011) (1)
Management of complex liver diseases. (2021) (1)
Impact of locoregional therapy on post-transplant outcomes in patients with hepatocellular carcinoma beyond Milan criteria (2021) (1)
P0074 : Prevalence and risk factors of metabolic syndrome after liver transplantation: a single centre experience (2015) (1)
FRI-403-Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome (2019) (1)
Role of a dedicated referral system for patients with liver disease and potential indication for liver transplantation: prospective data from a single centre experience (2020) (1)
Obtaining SVR To Antiviral Therapy Highly Protects Patients With HCV Recurrence On The Graft After Liver Transplantation From Liver Related Death: Insights from The AISF-RECOLT-C GROUP. (2011) (1)
Adherence to surviving sepsis campaign 3-hour bundles improves survival in non-critically ill patients with cirrhosis and sepsis (2020) (1)
OC-24 Interaction between cyclosporine and recipient IL-28B rs12979860 C>T genetic polymorphisms in the achievement of sustained viral response for recurrent hepatitis C (2012) (1)
Portal vein thrombosis in cirrhosis: Predictors of successful anticoagulation therapy (2014) (1)
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy (2022) (1)
De Novo Malignancies Following Liver Transplantation. Results from a Multicentric Study; Italy 1990-2010. (2013) (1)
Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation. (2019) (1)
[Peptic ulcer and liver cirrhosis. Clinico-epidemiologic considerations]. (1990) (1)
LP51 : Treatment of severe HCV recurrence after liver transplantation with sofosbuvir based regimen: Results of the aisf-sofolt Italian compassionate use program (2015) (1)
HCC criteria for liver transplantation: Controversies (2015) (1)
von Willebrand factor in hospitalized patients with acute decompensation of cirrhosis is increased but not associated with development of ACLF. (2022) (1)
Adult living donor liver transplantation and innovative protocols. A single institutional experience (2007) (1)
Evaluation of graft and recipient risk factors in liver transplantation (2009) (1)
Compliance to medical regimen in patients before and after liver transplantation: Are there any predictive factors? (2007) (1)
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. (2013) (1)
186 EFFECT OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) ON THROMBIN GENERATION IN CIRRHOTIC PATIENTS AT DIFFERENT STAGES OF LIVER DISEASE (2011) (1)
Validation of the INCREMENT‐SOT‐CPE score in a large cohort of liver transplant recipients with carbapenem‐resistant Enterobacterales infection (2023) (1)
The Need for Consensus About Liver Transplantation For Patients With Neuropsychiatric Wilson’s Disease (2021) (1)
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review. (2023) (1)
Adult Liver Stem Cells (2014) (1)
Role of HCV infection in the development of lymphoproliferative disorders in organ transplant recipients (OT) (2000) (1)
Continuous infusion of beta-lactam antibiotics in cirrhotic patients with bloodstream infection: results from a prospective multicentre observational study (2018) (1)
Coronary microvascular dysfunction in patients with advanced liver cirrhosis: the missing piece of the puzzle for understanding cirrhotic cardiomyopathy? (2013) (1)
P931 EFFECTS OF NON-SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP) (2014) (1)
Differentiation of mesenchymal stem cells (MSCs) from human umbilical cord (HUC) into hepatocyte-like cells (2006) (1)
A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis (2020) (1)
610 FUNCTIONAL STUDY OF THE INTESTINAL BARRIER IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION (2011) (1)
P1281 GENERATION AND PERFORMANCE OF VALUE-BASED OUTCOME INDICATORS IN LIVER DISEASE: THE MULTICENTER V.B.M.H. STUDY (2014) (1)
The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation (2020) (1)
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma (2021) (1)
Acute alcoholic hepatitis and liver transplantation: Waiting for Godot (2017) (1)
Mo2008 Ameliorative Potentials of Human Umbilical Cord Derived Mesenchymal Stem Cells in Dextran Sulphate Sodium Induced Acute Colitis in NOD.Cb17-Prkdcscid/J Mice (2012) (1)
The era of the new directly acting antivirals: Has the time come for kidney transplant only in compensated cirrhosis? (2015) (1)
Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus. (2011) (1)
T-52 The role of immunity and gender during acute liver injury (2013) (1)
The two faces of hepatocellular carcinoma prognostic evaluation: ‘observational’ or ‘pragmatic’ approach? (2004) (1)
How to identify patients with the need for early liver re-transplant? Development and validation of a comprehensive model to predict Early Allograft Failure (2020) (1)
Multidrug-Resistant Bacterial Infections before and after Liver Transplantation (2020) (1)
Filling the gap between clinical trials and real life in the treatment of severe HCV recurrence after liver transplantation (2017) (1)
Subcutaneous hepatitis B immunoglobulin after liver transplantation. Reply (2012) (1)
788 INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE? (2009) (1)
Estimation of the harm to the waiting list as crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation (2009) (1)
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice (2022) (1)
Early liver transplantation for severe acute alcoholic hepatitis: Pilot program in a single transplant centre in Italy (2017) (1)
OC-10 Effect of low molecular weight heparin (LMWH) on thrombin generation in cirrhotic patients (2011) (1)
[Neuroendocrine tumors and liver transplantation: review based on a case report]. (1997) (1)
473 NON ADHERENCE TO MEDICAL PRESCRIPTIONS IN LIVER TRANSPLANTATION: A PROSPECTIVE LONGITUDINAL STUDY (2010) (1)
P.284 Neurocognitive alterations in patients with HCV infection with and without abnormal transaminases (2006) (1)
Histological features of donor grafts for orthotopic liver transplantation. (2001) (1)
701 PHARMACOKINETICS, EFFICACY AND SAFETY OF INTRAMUSCOLARE AND INTRAVENOUS OF HEPATITIS B IMMUNOGLOBULINS COMBINED WITH NUCLEOSIDE ANALOGUES IN PROPHYLAXIS OF HEPATITIS B AFTER LIVER TRANSPLANTPHARMACOKINETICS, EFFICACY AND SAFETY OF INTRAMUSCULAR AND INTRA (2008) (1)
State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection (2021) (1)
From the Editor's Desk…. (2021) (1)
Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical outcome (2011) (1)
Reply to: Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant (2015) (1)
Liver Retransplantation for Hepatic Abscess Due to Hepatic Artery Thrombosis: A Case Report. (2017) (1)
HBV-DNA detected by PCR in serum and liver during the follow up of HBsAg positive transplanted patients (1993) (1)
Peg-ifn-alfa 2b With Ribavirin for the Treatment of Mild-moderate Recurrent Hepatitis C After Liver Transplantation (lt) : Impact On Fibrosis Progression. a Multicenter Randomized Controlled Study (2009) (1)
Thromboelastographic evaluation of hemostatic balance in cirrhotic patients with infection (2017) (1)
An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know. (2021) (1)
THE IMPACT OF POOR ADHERENCE TO MEDICAL REGIMEN IN LIVER TRANSPLANTATION (LT): 707 (2008) (1)
Assessment of Adherence To Medical Regimen After Solid Organ Transplantation: the Experience of Padova University Hospital (2010) (1)
Friday, February 25thF-10 Acute and chronic rejection during interferon therapy in HCV recurrent transplant patients: Results from the AISF-RECOLT-C group (2011) (1)
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? (2010) (1)
The ILTS Consensus Conference on NAFLD/NASH and liver transplantation (2018) (1)
Non-invasive evaluation of change in liver fibrosis after viral eradication in patients with HCV related cirrhosis (2018) (1)
PRESENTAZIONE DI UN TRIAL RANDOMIZZATO PLURICENTRICO SCLEROTERAPIA VS. LEGATURA ELASTICA DELLE VARICI ESOFAGEE NEL MALATO CIRROTICO CANDIDATO AL TRAPIANTO DI FEGATO CON SANGUINAMENTO PREGRESSO IN ATTO (1994) (1)
Virus dell'epatite C nei pazienti in trattamento emodialitico in lista per trapianto di rene: l'esperienza di Padova (2006) (1)
Liver Transplantation (OLT) for Alcoholic Cirrhosis with Respect to Recidivism (1997) (0)
P0064 : Ribavirin pre-treatment in liver transplant patients with hcv recurrence: Results from pearl multicentre randomized trial (2015) (0)
Central Pontine and Extrapontine Myelinolysis: Risk Factors and Clinical Expression in Liver Transplanted Patients (P6.028) (2014) (0)
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving anti-viral therapy. (2020) (0)
From the Editor's Desk…. (2022) (0)
Long-term liver function changes and related risk factors after direct-acting antiviral therapy in HCV-infected cirrhotic patients: results from a prospective web-based regional platform (2019) (0)
Development of a model based on case-mix analysis to predict 6-month patient survival after liver transplantation: a multicenter Italian study (2019) (0)
OC-5 Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury (2012) (0)
15-year Evolution of Liver Transplantation in Europe. (2008) (0)
Posters (2018) (0)
The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation (2023) (0)
Effect of portal vein thrombosis (PVT) on survival after liver transplantation (LT): A meta-analysis (2014) (0)
ALBUMIN SYNTHESIS FROM ISOLATED RAT HEPATOCYTES (2004) (0)
Italian survey on HBV and liver transplantation in a cohort of 2260 patients (2014) (0)
NEUROPSYCHOLOGICAL AND NEUROPHYSIOLOGICAL EVALUATION IN CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY (MHE) UNDERGOING EVALUATION FOR LIVER TRANSPLANTATION (2004) (0)
Outcomes After Liver Transplantation for Hcc: A Meta-Analysis (2012) (0)
Renal Function Deterioration Is Higher Within The First Year After Liver Transplantation: Results of The Italian Cross-Sectional, Multicenter Study (SURF).: Abstract# C2000 (2014) (0)
GENDER AS PREDISPOSING FACTOR TO LIVER REGENERATION BY HEPATIC PROGENITOR CELLS PROLIFERATION AND STELLATE CELL ACTIVATION IN A MURINE MODEL OF ACUTE LIVER INJURY (2009) (0)
Chronic HBV/HCV hepatitis in heart transplant (HTx) recipients: open α-IFN treatment (1998) (0)
LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE NEEDLE IN THE HAYSTACK (2009) (0)
1070 IMMUNE RESPONSE AND GENDER DISPARITY INFLUENCE LIVER REGENERATION AFTER ACUTE HEPATIC INJURY (2011) (0)
P.1.128: FUNCTIONAL STUDY OF THE INTESTINAL BARRIER IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION (2011) (0)
348 Human umbilical cord (HUC) and HUC blood CD105-positive cells can differentiate in vitro into hepatocyte-like cells (2006) (0)
F-46 A novel model of priority assessment for patients with and without hepatocellular carcinoma on a common liver transplant waiting list: a multicentre, cohort study (2013) (0)
Letter to the editor: Is PAI‐1 a thrombotic biomarker in NASH cirrhosis? (2022) (0)
P.291 Anti-HCV positive patients with end stage renal disease (ESRD): assessment of liver disease before and after kidney transplantation (KT) (2006) (0)
Reply (2017) (0)
Single-photon emission computed tomography (SPECT) imaging of regional cerebral blood flow (rCBF) before and after orthotopic liver transplantation (OLTx) (1995) (0)
From the Editor's Desk…. (2021) (0)
Reassessment of the risk of recurrence (R3) after liver transplantation for HCC: validation of the R3 v.2 score and comparison with existing models: results of a multinational analysis in 2,444 patients (2020) (0)
University of Birmingham Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients (2017) (0)
827 THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (2009) (0)
Circulating microparticles and thrombotic risk in patients with HCV-related cirrhosis who underwent DAA treatment (2018) (0)
DE NOVO TUMORS AFTER LIVER TRANSPLANTATION: RESULTS FROM A MULTICENTRIC STUDY, ITALY 1990–2008.: 2190 (2010) (0)
From the Editor's Desk… (2020) (0)
P885 RECIPIENT AND DONOR GENDER MATCH PREDICTS THE OUTCOME OF ANTIVIRAL THERAPY FOR RECURRENT HEPATITIS C (2014) (0)
Umbilical cord (UC): a possible source of stem cell for hepatocyte differentiation (2005) (0)
Open α-IFN treatment of chronic HBV/HCV hepatitis in heart transplant (HTx) recipients (1998) (0)
Vascular liver diseases: A sex-oriented analysis of the literature. (2022) (0)
Evolution of liver transplantation for alcoholic liver disease: A single center study (2017) (0)
The Efficacy of CMV Specific Immune Reconstitution is Highly Dependent on Donor/Recipient Serostatus and Type of Solid Organ Transplanted (2018) (0)
Complicanze neurologiche dopo trapianto di organo solido (2008) (0)
From the Editor's Desk... (2023) (0)
P: 19 Predictive Value of Induced Hyperammonaemia and Neuropsychiatric Profiling in Relation to the Occurrence of Post-tips Hepatic Encephalopathy (HE) (2019) (0)
Graft-Related Transplant Benefit Based on MELD Score of the Recipient in Liver Transplantation (2011) (0)
From the Editor's Desk… (2020) (0)
Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice (2015) (0)
18F)fluorodeoxyglucose (FDG) positron emission tomography (PET) and neuropsychological study before and after liver transplantation (OLT) (1998) (0)
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study (2021) (0)
[Preservation of the liver with the University of Wisconsin solution. Clinical and experimental aspects]. (1991) (0)
206 THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS (2012) (0)
EVALUATION OF PHYSICIAN AGREEMENT FOR DEFINING "CLINICAL SUSPICION OF REJECTION" IN LIVER TRANSPLANTATION (2013) (0)
499 GENOTYPE 2 AND 3 RECCURENT HEPATITIS C AFTER LIVER TRANSPLANTATION: EXCELLENT RESULTS WITH SUBOPTIMAL DOSES OF ANTIVIRAL THERAPY (2009) (0)
OC.11.3 GENDER INFLUENCES MACROPHAGES CLEARANCE DURING LIVER REGENERATION IN A MOUSE MODEL OF ACUTE HEPATIC DAMAGE (2010) (0)
Cholestatic and HCV-Related Liver Disease Associated with Acute Rejection After Liver Transplantation (1997) (0)
23 Rat hepatocytes in primary culture seeded on homologous acellular matrix (HAM) (2003) (0)
Molecular staging of HCC patients eligible for potentially radical therapies (2008) (0)
How gender influences fibrosis regression in a chronic murine model of hepatic injury (2017) (0)
Myocardial perfusion scintigraphy to assess cardiac function in patients with cirrhosis before liver transplantation (2000) (0)
Sa1269 Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- a Systematic Review (2012) (0)
OC.05.3 ENDOTHELIAL DAMAGE IN THE PORTAL VEIN OF PATIENTS WITH CIRRHOSIS (2020) (0)
Management of portal hypertension severe complications (0)
Outcome of critically ill patients with cirrhosis and ACLF after ICU admission (2019) (0)
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) (2014) (0)
Cost-effectiveness of pre-transplant Sofosbuvir to prevent recurrence of HCV infection after liver transplantation (2015) (0)
Current Treatment Strategies and Future Possibilities for Sarcopenia in Cirrhosis. (2023) (0)
P477 VALUE-BASED OUTCOME INDICATORS IN LIVER CIRRHOSIS: VALIDATION IN A LARGE MULTICENTER STUDY (VBMH STUDY) (2014) (0)
articleBax Inhibitor-1 down-regulation in the progression of chronic liver diseases (2015) (0)
Third ELITA‐ELTR Winter Meeting March 24–26, 2007 (2007) (0)
OXIDATIVE DAMAGE IN CHRONIC AND ACUTE LIVER DISEASE. (1996) (0)
Neutrophil gelatinase-associated lipocalin predicts response to terlipressin and albumin in patients with hepatorenal syndrome (2022) (0)
From the Editor's Desk... (2022) (0)
Use of Anti-HCV Positive Grafts in Liver Transplantation (2014) (0)
Gender Influences Macrophage Clearence In A Murine Model of Acute Liver Injury (2011) (0)
P.16.10 EFFECTS OF NON SELECTIVE β-BLOCKERS (NSBB) ON HEMODYNAMICS AND PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION IN CIRRHOTIC PATIENTS UNDERGOING LARGE VOLUME PARACENTESIS (LVP) (2014) (0)
P973 VALUE-BASED APPROACH TO HEPATOCELLULAR CARCINOMA: OUTCOME INDICATORS TESTED IN A LARGE MULTICENTER STUDY (VBMH STUDY) (2014) (0)
From the Editor's Desk... (2023) (0)
OC.07.3 GENDER SUSCEPTIBILITY DURING ACUTE LIVER INJURY: ANY ROLE FOR THE ANDROGEN RECEPTOR? (2012) (0)
Insulin resistance improvement after effective Hepatitis C virus eradication and its role on the onset of complications of advanced liver disease (2018) (0)
Hypercoagulability in cirrhotic patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT) (2014) (0)
Detection of HBV-DNA by PCR in serum and liver during the follow up of HBsAg positive transplanted patients receiving hepatitis B immunoglobulin prophylaxis (1995) (0)
[A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer]. (1990) (0)
Transition of pediatric liver transplanted recipients to Adult Healthcare Service: A single center cohort (2016) (0)
Long-term liver fibrosis and outcomes in HCV-infected solid organ transplant recipients after DAAs-induced viral eradication (2020) (0)
the changing scenario of HBV chronic related disease in the transplant setting (2022) (0)
Extending transplantation criteria for hepatocellular carcinoma. (2017) (0)
PREDICTING THE TRANSPLANT BENEFIT IN PATIENTS WITH MULTI-NODULAR HEPATOCELLULAR CARCINOMA. ON BEHALF OF THE ITA.LI.CA STUDY GROUP.: 2113 (2010) (0)
SAT-115-Fondaparinux vs low molecular weight heparin in the treatment of non malignant portal vein thrombosis in patients with cirrhosis (2019) (0)
P.04.7 PREVALENCE OF DE NOVO METABOLIC SYNDROME AND ITS RISK FACTORS IN A LIVER TRANSPLANTED POPULATION: A PROSPECTIVE STUDY (2019) (0)
Complete response after biological downstaging in patients with hepatocellular carcinoma: XXL-like prioritization for liver transplantation or “waiting and see” strategy? (2021) (0)
523 PROTRACTED ANTIVIRAL TREATMENT BEYOND CONVENTIONAL TIME LIMITS IMPROVES SURVIVAL IN NON-RESPONDERS TO INTERFERON+RIBAVIRIN ADMINISTERED FOR HCV RECURRENCE AFTER LIVER TRANSPLANTATION (2011) (0)
E' POSSIBILE RAZIONALIZZARE I CONSUMI DI ALBUMINA PER PAZIENTE CIRROTICO? (2015) (0)
OC.04.1 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC STATUS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2014) (0)
342 CLINICAL PRESENTATION OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) ACROSS THE WORLD: DATA FROM THE GLOBAL NASH REGISTRY (2021) (0)
The histological activity index (HAI) is an early predictor ofcirrhotic evolution of recurrent hepatitis C in liver allografts (2000) (0)
OC-33 Evaluation of intestinal barrier function and histologic aspects “in vivo” and its normalization after β-blocker treatment in patients with cirrhosis and portal hypertension (2011) (0)
From the Editor's Desk... (2022) (0)
Influence of sex in alcohol‐related liver disease: Pre‐clinical and clinical settings (2023) (0)
Micronuclei in hepatocellular carcinoma and its phenotypical precursors (2006) (0)
CHANGING ATTITUDE TO ORGAN DONATION AND TRANSPLANTATION IN UNIVERSITY STUDENTS DURING THREE YEAR COURSE OF MEDICAL SCHOOL IN ITALY (2004) (0)
Prevlence and outcome of De novo malignancies after liver transplantation (OLT) (1998) (0)
Contributors (1962) (0)
Liver, Pancreas and Biliary Tract HCV infection in haemodialysed patients: A role for serum IL-10 and TGF-1 in liver damage? (2008) (0)
Il trapianto di fegato nei pazienti con epatocarcinoma. Risultati a lungo termine del Centro Trapianti di Padova. (1996) (0)
190 DE NOVO AUTO-IMMUNE HEPATITIS AND HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A CHALLENGING DIAGNOSIS AND POOR PROGNOSIS (2012) (0)
The role of delta creatinine and serum albumin in predicting mortality in patients with severe alcoholic hepatitis and infection (2019) (0)
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation (2017) (0)
HCC progression before liver transplantation: Dropout or salvage liver transplantation? (2007) (0)
From the Editor's Desk... (2022) (0)
COVID-19 and Solid Organ Transplantation (SOT) in Italy: A web-survey (2021) (0)
From the Editor’s Desk… (2022) (0)
Effectiveness and safety of DAA treatment for recurrent hepatitis C after liver transplantation: The NAVIGATOR Lombardia-Veneto network (2018) (0)
O32 PROSPECTIVE EVALUATION OF THE CORRELATION BETWEEN HEMOSTATIC ALTERATIONS AND INCIDENCE OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2014) (0)
Poster Presentations (2014) (0)
F-48 Liver transplantation for HBV-related liver disease: the experience of Padua Liver Transplant Center (2013) (0)
Patients with chronic HCV and decompensated cirrhosis are at risk for MELD purgatory (2022) (0)
228 MELD-NA AND SURVIVAL BENEFIT IN LIVER TRANSPLANTATION (2012) (0)
[141] LONG TERM FOLLOW-UP OF LIVER TRANSPLANTATION (OLT) FOR CHOLESTATIC AND AUTOIMMUNE END STAGE LIVER DISEASES (2007) (0)
Is osteopenia a peculiar association with primary biliary cirrhosis (PBC) (2001) (0)
The (HFDG) graft influence the outcome of LT (2001) (0)
Effects of Non-Selective β-Blockers on hemodynamic and Paracentesis Induced Circulatory Dysfunction in cirrhotics undergoing large volume paracentesis (2014) (0)
SEXUAL DYSFUNCTION (SD) AND QUALITY OF LIFE (QOL) AFTER LIVER TRANSPLANTATION (LT) IN MALE RECIPIENTS: 2043 (2008) (0)
From the Editor’s Desk… (2001) (0)
Gender dimorphism in fibrosis dynamics in a murine model of chronic hepatic injury (2018) (0)
Hepatitis C virus infection in haemodialysed patients: Role of IL-10 (2003) (0)
protocolA prospective randomised , open-labeled , trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma (2010) (0)
Medical Complications after Liver Transplantation (OLT): Impact on Quality of Life (QOL) (1997) (0)
Recent trends and intention-to-treat survival of liver transplantation for non-alcoholic steatohepatitis: an Italian liver transplant registry study. On behalf of AISF, FIRE, SITO and CNT (2020) (0)
From the Editor's Desk... (2021) (0)
From the Editor's Desk... (2020) (0)
Poster Presentations (2005) (0)
Evaluation of compliance in patients before and after liver transplantation (LT). (2006) (0)
Peripheral NK cells in patients with HCV recurrence after liver transplantation during interferon-free antiviral therapy (2016) (0)
Evaluation of the compliance of patients with alcoholic liver disease followed at gastroenterology outpatient clinic (2006) (0)
Transition of adolescents with pediatric-onset hepatobiliary diseases: systematic review of literature (2018) (0)
From the Editor’s Desk… (2020) (0)
From the Editor's Desk... (2022) (0)
Predictive factors of HCV recurrence after liver transplantation (OLTX) (2003) (0)
Erratum (2009) (0)
A LONGITUDINAL, PROSPECTIVE STUDY ON ADHERENCE TO MEDICAL REGIMEN BEFORE AND AFTER LIVER TRANSPLANTATION (2009) (0)
High donor-age vs High MELD in liver Tx. Which is the most effective approach? Evidences from the Italy-US D-MELD study (2014) (0)
1039 ALPHAFETOPROTEIN AND TRANSPLANT SURVIVAL BENEFIT FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA: A MULTICENTRE COHORT STUDY (2012) (0)
From the Editor's desk…. (2021) (0)
259 Micronuclei in hepatocellular carcinoma and its phenotypical precursors (2006) (0)
Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft (2004) (0)
208 Evaluation of compliance in patients with chronic liver disease (2006) (0)
Algorithm for the management of portal vein thrombosis: a prospective study in patients with liver cirrhosis (2011) (0)
Pregnancy after liver transplantation: a survey from Italian liver transplants centres (2021) (0)
Revised content underlined and in bold AISF Position Paper Common issues in the management of patients on the waiting list and after liver transplantation : HCV , HBV , alcoholic liver disease , immunosuppression (2016) (0)
www.D-MELD.com. THE ONLINE PROGNOSTIC CALCULATOR TO OPTIMIZE DONOR-RECIPIENT MATCH (2011) (0)
P.161 SELF-REPORTED ADHERENCE TO MEDICAL REGIMEN BEFORE AND AFTER LIVER TRANSPLANTATION (LT) (2010) (0)
Recipient and donor gender match predicts the outcome of antiviral therapy for recurrent hepatitis C (2014) (0)
424.4: The Protection From CMV Infection in Solid Organ Transplants Is Highly Dependent on CMV T-Cell Specific Immunity And Type of Organ Transplant (2022) (0)
THE BENEFIT OF ANTIVIRAL THERAPY ON FIBROSIS PROGRESSION DUE TO HCV RECURRENCE AFTER LIVER TRANSPLANTATION (LT): AN ITALIAN MULTICENTER STUDY (2009) (0)
External validation of the HCC-MELD score for patients with hepatocellular carcinoma waiting for liver transplantation (2017) (0)
Hepatocellular carcinoma and the risk of cancer onset after liver transplantation-role of immune activation and aging profiles (2022) (0)
HIGH MELD VERSUS HIGH DONOR AGE: LESSONS LEARNED COMPARING THE AMERICAN AND THE ITALIAN LIVER TRANSPLANT EXPERIENCES (2013) (0)
The role of alcoholic liver disease as risk factor for the development of de novo metabolic syndrome after liver transplantation: a prospective longitudinal study (2019) (0)
The un-sustainable match in HCV recipients : Evidences from the italian D-MELD study on balancing donor-recipent risk factors (2012) (0)
OC.03.9 SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS NOT ASSOCIATED WITH HIGHER MORTALITY IF COMPARED WITH OTHER INFECTIONS IN PATIENTS AWAITING LIVER TRANSPLANTATION (LT) (2016) (0)
Outcome of liver transplant recipients after the first episode of bacterial infection (2017) (0)
A method for establishing allocation equity among patients with HCC Vitale J Hepatology 14 (2014) (0)
Human umbilical cord blood: a possible source of stem cells for hepatocyte differentiation (2006) (0)
Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock? (2022) (0)
From the Editor’s Desk… (2001) (0)
T.N.46 A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY (2010) (0)
Transplantation of the liver (2001) (0)
Fibrosis progression on protocol liver biopsies in patients with HCV recurrence following liver transplantation (LT) (2008) (0)
From the Editor's Desk…. (2020) (0)
Prothrombotic microparticles and risk of portal vein thrombosis in patients with HCV-related liver cirrhosis who underwent DAA antiviral therapy (2017) (0)
Alfa-IFN (N3) plus ribavirin treatment in HCV recurrence after liver transplantation (OLT) (2002) (0)
Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients (2022) (0)
Complicanze infettive nel trapianto di fegato in Italia: stato attuale e prospettive di studio (2001) (0)
INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC): TO TACE OR NOT TO TACE? (2009) (0)
Plasma levels of MMP-2,TIMP-1 and PIIIP as markers of liver disease in hepatitis C recurrent after liver transplantation (2001) (0)
219 THE RELATIONSHIP BETWEEN SEXUAL DYSFUNCTION (SD) AND QUALITY OF LIFE (QOL) IN MALE AFTER LIVER TRANSPLANTATION (2008) (0)
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY.: 2299 (2010) (0)
Utility based criteria to select patients with hepatocellular carcinoma for liver transplantation: a multicentre cohort study (2015) (0)
P0065 : Effect of portal vein thrombosis (PVT) on survival after liver transplantation (LT): A metanalysis (2015) (0)
From the Editor's Desk... (2022) (0)
F.N.14 ALGORITHM FOR THE TREATMENT OF PORTAL (PVT) AND SPLANCNINC VEINS THROMBOSIS (SVT) IN PATIENTS WITH LIVER CIRRHOSIS (2010) (0)
Endothelial portal venous damage is associated with alterations in local TM and EPCR expression in patients with cirrhosis and portal hypertension (2020) (0)
General assessment and management (2015) (0)
OC.13.8: Coronary Microvascular Dysfunction in Patients with Decompensated Cirrhosis: Another Tool for Understanding Cirrhotic Cardiomyopathy? (2017) (0)
From the Editor's Desk…. (2020) (0)
Is liver damage due to HCV recurrence after transplantation associated with histological features of donor graft (2001) (0)
From the Editor's Desk... (2022) (0)
Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study Group (2018) (0)
Portal endothelial damage in cirrhosis (2019) (0)
P.18.2 LONG-TERM MAINTENANCE OF SVR IN DIFFICULT-TO-TREAT HCV GENOTYPES IN LIVER TRANSPLANT RECIPIENTS WITH HCV RECURRENCE (2013) (0)
PEG-IFN-alfa 2b WITH RIBAVIRIN FOR THE PREVENTION OF HISTOLOGICAL FIBROSIS PROGRESSION IN PATIENTS WITH HCV HEPATITIS RECURRENCE. A MULTICENTER RANDOMIZED CONTROLLED STUDY. INTERIM REPORT (2009) (0)
P0030 : Utility based criteria to select patients with hepatocellular carcinoma for liver transplantation: A multicentre cohort study (2015) (0)
De novo metabolic syndrome after liver transplantation: a prospective, longitudinal study (2020) (0)
De Novo Autoimmune Hepatitis Associated with HCV Recurrence After Liver Transplantation: A Bicentric Experience (2012) (0)
Genotypes 2 and 3 recurrent hepatitis C after liver transplantation: Excellent results with suboptimal doses of antiviral therapy (2009) (0)
WHAT DOES HAPPEN TO THE DONOR HISTOLOGICAL FEATURES AFTER LIVER TRANSPLANTATION? (2004) (0)
PC.01.5 INFECTIONS IN CIRRHOSIS: A CHANGING EPIDEMIOLOGIC SETTING (2020) (0)
A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3) (2014) (0)
Immunosoppressione e tumore: un confronto dei rischi nei pazienti sottoposti a trapianto d'organo e persone con infezione da HIV (2006) (0)
Whole Blood Coagulation Tests are not Equally able to Detect Haemostatic Prothrombotic Alterations in Patients with Liver Cirrhosis and Hepatocellular Carcinoma: Rotational Thromboelastometry versus Thrombingeneration Test (2016) (0)
From the Editor's Desk... (2021) (0)
S1007 Genotype 2 and 3 Reccurent Hepatitis C After Liver Transplantation: Excellent Results with Suboptimal Doses of Antiviral Therapy (2009) (0)
141 USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE (2013) (0)
Contents (2020) (0)
T06.01.4 IMPACT OF PRE-TRANSPLANT SARCOPENIA ON SHORT TO MEDIUM TERM OUTCOME IN LIVER TRANSPLANT RECIPIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA (2020) (0)
From the Editor's Desk…. (2020) (0)
Questioni aperte e futuri sviluppi nel trapianto di fegato (2017) (0)
MELD-Na and Survival Benefit in Liver Transplantation: 2368 (2012) (0)
New insight in the biologic support of rat hepatocytes in primary culture (2003) (0)
High MELD vs High Donor Age: Two Different Approaches, Similar Results. Evidences from US and Italy (2013) (0)
The role of the steatosis of the donor graft on histological features after liver transplantation (LT) (2003) (0)
Preliminary report of open α-IFN (N-3) treatment of chronic HBV/HCV hepatitis in heart transplant (HTx) recipients (2000) (0)
Role of hepatotropic viruses in the development of lymphoproliferative disorders in organ transplant recipient (2000) (0)
Liver transplantation (LT) for alcoholic liver disease in adults in Europe (2008) (0)
HCV and HBV infection in hemodialysis (HD) patients: risk factors for liver disease (LD) after renal transplantation (RTx) (1998) (0)
L’impatto delle neoplasie de novo sulla sopravvivenza nei trapiantati di fegato (2018) (0)
Transplanting severely obese cirrhotic patients: Heavy clouds still on the horizon (2022) (0)
P0027 : Cost-effectiveness of pre-transplant sofosbuvir to prevent recurrence of HCV infection after liver transplantation (2015) (0)
F-33 Predictors of response to anticoagulant therapy for the treatment of portal vein thrombosis (PVT) in cirrhosis patients (2013) (0)
HCV RECURRENCE ON PROTOCOL LIVER BIOPSIES AFTER LIVER TRANSPLANTATION: 1261 (2008) (0)
Qualità di vita dopo trapianti d’organo (2012) (0)
Strutturazione e implementazione di interventi educativi rivolti a giovani pazienti sottoposti a trapianto di fegato. Un progetto pilota condotto presso l’Azienda Ospedaliera e l’Università di Padova (2019) (0)
Plasma levels of MMP-2, TIMP-1, and PIIIP as markers of liver disease in hepatitis C recurrent after liver transplantation (2001) (0)
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience (2016) (0)
6 OC Evaluation of myocardial function in patients undergoing liver transplantation (2002) (0)
The survival benefit of liver transplantation in patients with hepatocellular carcinoma (2009) (0)
Contents (2020) (0)
Educazione di pazienti in lista d’attesa e dopo trapianto di organi solidi (2009) (0)
From the Editor's Desk... (2020) (0)
Bone metabolism in male subjects undergoing liver transplantation (OLTx) (2000) (0)
148 LIVER TRANSPLANTATION IN CIRRHOTIC PATIENTS WITH MELD SCORE 18: A NEW PROGNOSTIC MODEL TO PREDICT DROP-OUT FROM THE WAITING LIST (2013) (0)
581 THE NEW CONCEPT OF “GRAFT SURVIVAL BENEFIT’ IN LIVER TRANSPLANTATION (2011) (0)
Contents (2020) (0)
Sessualità e gravidanza nelle donne prima e dopo trapianto di fegato (2009) (0)
Validation of a method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common waiting list (2016) (0)
789 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE NEEDLE IN THE HAYSTACK (2009) (0)
465 CAN WE SAFELY USE DONOR LIVERS WITH STEATOSIS IN HCV-POSITIVE RECIPIENTS? (2009) (0)
From the Editor's Desk... (2021) (0)
From the Editor's Desk... (2021) (0)
Reply (2012) (0)
The impact of IL-28B polymorphism and diabetes on SVR after antiviral therapy (AT) for post-liver transplant (LT) HCV recurrence (2014) (0)
F-25 Prospective validation of noninvasive methods to assess liver fibrosis in HCV patients after liver transplantation (LT) (2012) (0)
Effects of non-selective β-blockers on hemodynamics and paracentesis induced circulatory dysfunction in patients with cirrhosis undergoing large volume paracentesis (2014) (0)
OC-28 Behind D-MELD: the role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants (2012) (0)
Confronto tra legatura endoscopica e trattamento con beta-bloccanti per la profilassi primaria del sanguinamento da varici esofagee in pazienti candidati a trapianto di fegato: risultati preliminari di un trial clinico randomizzato. (2006) (0)
Increased platelet aggregation in patients with cirrhosis and hepatocellular carcinoma: A new potential therapeutic target? (2021) (0)
Hemostatic status and portal vein thrombosis (PVT) in cirrhotic patients with hepatocellular carcinoma (HCC) (2014) (0)
From the Editor's Desk (1957) (0)
Long-term liver fibrosis and outcomes in HCV-infected solid organ transplant recipients after DASSs-induced viral eradication (2020) (0)
Presentation and outcome in patients with drug induced liver injury: A three-year experience (2016) (0)
From the Editor's Desk…. (2020) (0)
Human umbilical cord blood and umbilical cord mesenchymal stem cells can contribute to liver regeneration in an animal model of chemical-induced injury (2009) (0)
Educazione alla salute in giovani pazienti sottoposti a trapianto di fegato. Progetto pilota di strutturazione e implementazione di strumenti di dialogo educativo condotto presso l’Azienda Ospedaliera di Padova (2017) (0)
Single-photon emission computed tomography in cirrhotic patients with minimal neurological abnormalities (1995) (0)
HBV-DNA SIERICO E TESSUTALE IN PCR IN TRAPIANTO DI FEGATO PER MALATTIA EPATICA HBV-CORRELATA (1995) (0)
Sa349 A GLOBAL SURVEY OF PHYSICIANS KNOWLEDGE ABOUT NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) (2021) (0)
THU-071-Matrix modulation in chronic liver injury and resolution (2019) (0)
Effects of Non-Selective beta-Blockers on Hemodynamics and Paracentesis Induced Circulatory Dysfunction in Patients with Cirrhosis Undergoing Large Volume Paracentesis: a Preliminary Report (2014) (0)
F-18 Graft related gain in life expectancy according to MELD score in liver transplantation (2011) (0)
Safety and efficacy of everolimus initiation from the first month after liver transplantation: A systematic review and meta-analysis. (2023) (0)
Anorexia and resting energy-expenditure (REE) in cirrhotic patients:Role of plasma concentrations of leptin and tumor necrosisfactor-α (TNF-α) (2000) (0)
P.04.17 IMPACT OF DAA IN PATIENTS WHO UNDERGOING SOLID ORGAN TRANSPLANTATION (2019) (0)
Acute Cellular Rejection in Liver Transplanted Patients: Incidence, Risk Factors, and Impact on Outcome (2010) (0)
Therapeutic approaches for the treatment of aging-induced stem cell dysfunction (2021) (0)
“DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?” (2017) (0)
Can the Un-Sustainable Match Be Identified in Liver Transplant Population? Evidencies from the Italian Donor-2-Recipient D-Meld Study: 2566 (2012) (0)
PREVALENCE AND DISTRIBUTION OF GENOTYPES OF TRANSFUSION TRANSMITTED VIRUS (TTV) INFECTION IN LIVER TRANSPLANTED PATIENTS (2004) (0)
Isoniazid‐related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation (2004) (0)
Il trapianto epatico negli alcolisti (2000) (0)
Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.) Liver Transplantation in Italy: current status (2000) (0)
Gli adolescenti e il trapianto di fegato (2012) (0)
Histological HCV recurrence after liver transplantation (LT): The impact of antiviral therapy on fibrosis progression (2008) (0)
P1301 THE ITA.LI.CA CRITERIA TO SELECT PATIENTS WITH HEPATOCELLULAR CARCINOMA FOR LIVER TRANSPLANTATION: A NOVEL APPROACH BASED ON TRANSPLANT BENEFIT ANALYSIS (2014) (0)
Gender influences macrophages clearance and immunoresponse during liver regeneration in a mouse model of acute hepatic damage (2010) (0)
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative study. (2021) (0)
Laparoscopic ablation and salvage transplantation for patients with hepatocellular carcinoma (2016) (0)
P.09.5 ASSESSING THE RISK OF DE NOVO NEOPLASMS AFTER LIVER TRANSPLANTATION: ROLE OF HEPATOCELLULAR CARCINOMA (2018) (0)
3 P A new support for hepatocyte culture based on homologous acellular matrix (HAM) (2002) (0)
Proliferazione epatocellulare ed apoptosi in relazione al danno ossidativo nelle epatopatie alcol-correlate (2001) (0)
In Memoriam: Paolo Muiesan. (2022) (0)
OC.01.2 DE NOVO NEOPLASMS AFTER LIVER TRANSPLANTATION: DONOR GENDER AND AGE INFLUENCE (2019) (0)
227 Neuropsychological and neurophysiological evaluation in patients with liver cirrhosis and minimal hepatic encephalopathy (MHE) (2004) (0)
La dimensione del problema delle malattie digestive (epidemiologia, costi, impatto sociale) (2001) (0)
Assessing the risk of de novo neoplasms after liver transplantation: Role of pre-transplant hepatocellular carcinoma (2018) (0)
SAT-262-Long-term liver function outcome and related risk factors in HCV cirrhotic patients treated with direct-acting antiviral therapy: Results from the Navigatore platform in Veneto-Italy (2019) (0)
EFFECTS OF CYCLOSPORINE IMMUNOSUPPRESSIVE THERAPY ON HUMAN HEMATOPOIESIS IN LIVER TRANSPLANTED PATIENTS (1999) (0)
T-40 Alphafetoprotein and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre cohort study (2012) (0)
From the Editor's Desk... (2023) (0)
O7 FUNCTIONAL STUDY OF INTESTINAL BARRIER IN PATIENTS WITH LIVER CIRRHOSIS AND PORTAL HYPERTENSION (2012) (0)
188 THROMBIN GENERATION IN PATIENTS WITH PORTAL VEIN THROMBOSIS (PVT) WITH AND WITHOUT CIRRHOSIS (2011) (0)
Resting energy-expenditure (REE) in cirrhotic patients: Role of plasma concentrations of leptin and tumor necrosis factor-a (TNF-a) (2000) (0)
Cordone ombelicale umano come fonte di cellule staminali mesenchimali per il differenziamento epatico (2006) (0)
P.04.13 THE ROLE OF IMMUNE PROFILE IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS IN PREDICTING MORTALITY AND THE DEVELOPMENT OF INFECTIONS: A PROSPECTIVE EVALUATION (2019) (0)
Liver Transplantation during the COVID-19 pandemic: A quantitative model balancing individual patient benefit against population healthcare needs (2021) (0)
A NEW ALLOCATION MODEL FOR LIVER TRANSPLANTATION COMBINING URGENCY BASED PRIORITIZATION WITH DONOR-RECIPIENT MATCHING: A PROSPECTIVE CONTROLLED STUDY (2011) (0)
Erratum to ''A method for Liver Liver transplantation NITp working group Erratum (2013) (0)
P.1.2: THE PERSISTENCE OF HCV REPLICATION IS ASSOCIATED WITH AN INCREASED MORTALITY RATE IN HCV RECURRENT TRANSPLANT PATIENTS: RESULTS FROM THE AISF-RECOLT-C GROUP (2011) (0)
Validation of 2 Explant-Based Recurrence Prognostic Models after Liver Transplantation for Hepatocellular Carcinoma in an External Cohort (2016) (0)
Uncovering some ignored pioneering works on post-infectious irritable bowel syndrome (2014) (0)
From the Editor's Desk…. (2021) (0)
SAT-034-The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability (2019) (0)
From the Editor's Desk... (2022) (0)
Cellule CD105 + da sangue cordonale umano presentano potenzialità differenziativa epatica (2006) (0)
Toward a novel evidence‐based definition of early allograft failure in the perspective of liver retransplant (2021) (0)
Hyperinsulinemic response to oral glucose tolerance test (OGTT) is amplified in cirrhotics with active alcohol drinking: A facilitating role for sodium retention? (2000) (0)
Trapianto di fegato e gravidanza (2000) (0)
Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis. (2017) (0)
Mo1938 The Presence of Diabetes Reduces SVR After Antiviral Therapy for Post-Transplant HCV Recurrence (2012) (0)
Sofosbuvir plus ribavirin for difficult to treat HCV-2: improved efficacy with extended treatment duration. (2016) (0)
The ethical equipoise in living and deceased donor liver transplantation: Towards decision processes based on mathematical models (2009) (0)
Decreased hypercoagulable state in hepatitis C virus-cirrhotic patients treated with DAA: the outcome revolution (2017) (0)
THE USE OF MACHINE PERFUSION IN SURGICAL ONCOLOGY AND SPLIT LIVER TRANSPLANTATION (2023) (0)
OUTCOME IN KIDNEY TRANSPLANT PATIENTS WITH HEPATITIS C (HCV) INFECTION (2004) (0)
Circulating ICAM-1 in chronic liver disease —Evidence for lymphocyte activation in PBC & PSC? (1991) (0)
Gastrointestinal (G.I.) complications in heart transplant (HTX) recipients (1998) (0)
From the Editor’s Desk… (2021) (0)
Impact of Recruitment Maneuvers to Cover Adverse Effects of Donor Transfer. (2019) (0)
Renal Dysfunction in Hepatitis C Virus and Hepatocellular Carcinoma Patients after Liver Transplantation: Preliminary Results of the Italian Cross-sectional, Multicenter Study (surf) Cohort (2013) (0)
Neurocognitive evaluation in patients with hepatitis virus cinfection (2006) (0)
Infection in cirrhosis: a changing epidemiologic setting (2020) (0)
From the Editor's Desk…. (2020) (0)
F.N.48 INFLUENCE OF DONOR–RECIPIENT VARIABLES ON SHORT TERM PATIENT SURVIVAL FOLLOWING LIVER TRANSPLANTATION (LT) (2010) (0)
Reappraisal of prognostic value of MELD-Na score: A new tool for liver transplant prioritization in HCV-infected patients (2014) (0)
Acute Cellular Rejection and Outcomes after Liver Transplantation: A Protocol Biopsy Evaluation. (2013) (0)
OC-20 Prophylaxis of hepatitis B after liver transplantation: report of an Italian survey in a cohort of 2260 patients (2013) (0)
371 Transplantation into gunn rats of rat hepatocyte-homologous acellular matrix (HAM) sandwich (2006) (0)
The Role of N-Acetylcisteine, Protecting the Graft from the Fibrosis Progression Due To HCV Recurrence, after Liver Transplantation. Long Terms Results of a Randomized Controlled Study. (2014) (0)
CONCURRENT SESSION 79: THE CHALLENGE OF HEPATITIS B AND C IN TRANSPLANTATION (2006) (0)
Homologous acellular matrix (HAM): a new support for hepatocyte culture (2002) (0)
Risk of renal cell cancer in people immunodepressed after solid organ transplant: Results from an Italian multicenter cohort study. (2014) (0)
Mo1939 SVR to Antiviral Treatment for Post-OLT Recurrent HCV Hepatitis Can Be Improved by the use of Growth Factors (2012) (0)
OC.13.1: Eradication of HCV in Patients Awaiting Liver Transplantation does not Increase Drop-Out Due to HCC Progression (2017) (0)
131 Female HCV cirrhosis liver transplant recipients have worse fibrosis progression due to recurrent hcv than male HCV recipients (2006) (0)
From the Editor's Desk... (2021) (0)
UEG position paper: Obesity and digestive health (2022) (0)
OC.03.7 CIRCULATING MICROPARTICLES AND RISK OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA (2016) (0)
Liver transplantation for hepatocellular carcinoma: Results of a six-year experience (1997) (0)
P884 DONOR/RECIPIENT GENDER MISMATCH MODIFIES THE IMPACT OF DONOR AGE ON GRAFT SURVIVAL FOLLOWING LIVER TRANSPLANTATION (2014) (0)
Evaluation of the rat liver microcirculation by intravital microscopy during human blood xenoperfusion (2003) (0)
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) (2014) (0)
P.04.10 HBV-HDV RELATED LIVER DISEASE AS INDICATION FOR LIVER TRANSPLANTATION: A SINGLE CENTER STUDY (2019) (0)
OC-18 Liver transplantation in cirrhotic patients with MELD score <18: a new model to predict drop-out from the waiting list (2013) (0)
Liver transplantation (OLTx) for FHF: A score aided decision making process (1995) (0)
Cancer risk of aged people with HIV infection and of transplant people. (2006) (0)
Local prothrombotic state in portal venous system in cirrhosis (2017) (0)
PA.191 COMBINED ANTIVIRAL THERAPY(PEG-IFN +RIBAVIRINE) IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION. AN ITALIAN EXPERIENCE OF TWO TRANSPLANT CENTRES (2008) (0)
T.N.49 FIBROSIS PROGRESSION IN NON RESPONDERS TO ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE FOLLOWING LIVER TRANSPLANTATION (LT) (2010) (0)
International, multicenter study on the outcome of locoregional therapy before liver transplant for hepatocellular carcinoma extending the Milan criteria (2020) (0)
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis. (2023) (0)
From the Editor's Desk... (2022) (0)
Pre-emptive post-liver transplant hepatitis C virus treatment with daas: proof of concept from a pilot study (2017) (0)
Lean non-alcoholic fatty liver disease patients from the global NASH registry (2022) (0)
F-34 Risk factors for central pontine (CPM) and extrapontine myelinolysis (EPM) in liver transplanted recipients: a single center analysis (2012) (0)
The guts of the matter: UEG's role in European Union health policy developments (2023) (0)
From the Editor's Desk... (2023) (0)
Differenziamento di cellule staminali mesenchimali da cordone ombelicale in cellule simil epatocitarie. (2005) (0)
From the Editor's Desk... (2020) (0)
F-24 Immune response and gender disparity influence liver regeneration after acute hepatic injury (2011) (0)
Sexual Function, Fertility, and Pregnancy in Liver Disease and after Liver Transplantation (2021) (0)
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study (2010) (0)
Veno occlusive disease: up-date on clinical menagement. (2007) (0)
Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation (2020) (0)
Contents (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Patrizia Burra?

Patrizia Burra is affiliated with the following schools:

Patrizia Burra's Academic­Influence.com Rankings

Patrizia Burra's Degrees

Similar Degrees You Can Earn

Why Is Patrizia Burra Influential?

Patrizia Burra's Published Works

Published Works

What Schools Are Affiliated With Patrizia Burra?

Patrizia Burra's AcademicInfluence.com Rankings